These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10991699)

  • 21. Imaging-guided biopsy detects prostate cancer.
    Printz C
    Cancer; 2013 May; 119(10):1767. PubMed ID: 23649489
    [No Abstract]   [Full Text] [Related]  

  • 22. [Systematic vs. targeted prostate biopsy: integration or transition?].
    Kawakami S
    Nihon Rinsho; 2016 May; 74 Suppl 3():355-8. PubMed ID: 27344756
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of magnetic resonance imaging in the detection of prostate cancer.
    Choi S
    J Urol; 2011 Oct; 186(4):1181-2. PubMed ID: 21849178
    [No Abstract]   [Full Text] [Related]  

  • 24. Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer.
    Kumar V; Jagannathan NR; Thulkar S; Kumar R
    Int J Urol; 2012 Jul; 19(7):602-13. PubMed ID: 22435389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alternative for ultrasonographic assessment: role of magnetic resonance with endorectal coil for prostate and seminal vesicle biopsy].
    Giannotti P; De Maria M; Cuttano MG
    Arch Ital Urol Androl; 2000 Dec; 72(4):161-2. PubMed ID: 11221029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
    Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
    Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years.
    Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS
    J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectroscopy in prostate cancer: hope or hype?
    Roach M; Kurhanewicz J; Carroll P
    Oncology (Williston Park); 2001 Nov; 15(11):1399-410; discussion 1415-6, 1418. PubMed ID: 11758871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Words of wisdom: re: transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
    Ravery V
    Eur Urol; 2013 Aug; 64(2):337. PubMed ID: 23830225
    [No Abstract]   [Full Text] [Related]  

  • 30. Biopsy diagnosis of prostatic cancer--current areas of concern.
    Feneley MR; Parkinson MC
    J Clin Pathol; 1997 Apr; 50(4):265-6. PubMed ID: 9215135
    [No Abstract]   [Full Text] [Related]  

  • 31. Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: a Scottish experience.
    Mukherjee A; Morton S; Fraser S; Salmond J; Baxter G; Leung HY
    Scott Med J; 2014 Nov; 59(4):204-8. PubMed ID: 25314954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric Prostate Magnetic Resonance Imaging at 3 T: Failure of Magnetic Resonance Spectroscopy to Provide Added Value.
    Platzek I; Borkowetz A; Toma M; Brauer T; Meissner C; Dietel K; Wirth M; Laniado M
    J Comput Assist Tomogr; 2015; 39(5):674-80. PubMed ID: 25938212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MRI for troubleshooting detection of prostate cancer].
    Beyersdorff D; Hamm B
    Rofo; 2005 Jun; 177(6):788-95. PubMed ID: 15902626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved biopsy efficiency with MR/ultrasound fusion-guided prostate biopsy.
    Kim EH; Andriole GL
    J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27130934
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnetic resonance imaging of the prostate.
    Iversen P; Kjaer L; Thomsen C; Henriksen O
    Scand J Urol Nephrol Suppl; 1987; 104():41-5. PubMed ID: 3481468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.
    Amsellem-Ouazana D; Younes P; Conquy S; Peyromaure M; Flam T; Debré B; Zerbib M
    Eur Urol; 2005 May; 47(5):582-6. PubMed ID: 15826747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined usage of diffusion-weighted magnetic resonance imaging and transrectal ultrasound for transrectal prostate biopsy: a preliminary study].
    Wang JY; Shen YJ; Liu XH; Zhang HL; Ye DW; Yao XD; Zhang SL; Dai B; Zhu Y; Zhou LP
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):512-5. PubMed ID: 22490151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
    Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
    Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.